These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36651183)

  • 21. Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Bittermann T; Mahmud N; Weinberg EM; Reddy KR
    Transplantation; 2022 Jul; 106(7):1401-1410. PubMed ID: 35349533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboelastography Parameters Are Associated with Cirrhosis Severity.
    Kohli R; Shingina A; New S; Chaturvedi S; Benson A; Biggins SW; Bambha K
    Dig Dis Sci; 2019 Sep; 64(9):2661-2670. PubMed ID: 30915655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery.
    Jones BE; Allegretti AS; Pose E; Mara KC; Ufere NN; Avitabile E; Shah VH; Kamath PS; Ginès P; Simonetto DA
    Dig Dis Sci; 2022 Feb; 67(2):697-707. PubMed ID: 33604793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
    Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F
    J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of gastrointestinal hemorrhage and prediction of mortality in Asian patients with alcoholic hepatitis.
    Kim SH; Kim BG; Kim W; Oh S; Kim HY; Jung YJ; Jeong JB; Kim JW; Lee KL
    J Gastroenterol Hepatol; 2016 Apr; 31(4):814-21. PubMed ID: 26513408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis.
    Deltenre P; Trépo E; Fujiwara N; Goossens N; Marot A; Dubois M; Spahr L; Henrion J; Moreno C; Hoshida Y
    Liver Int; 2020 Mar; 40(3):565-570. PubMed ID: 31568650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
    Boike JR; Mazumder NR; Kolli KP; Ge J; German M; Jest N; Morelli G; Spengler E; Said A; Lai JC; Desai AP; Couri T; Paul S; Frenette C; Verna EC; Rahim U; Goel A; Gregory D; Thornburg B; VanWagner LB;
    Am J Gastroenterol; 2021 Oct; 116(10):2079-2088. PubMed ID: 34158464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.
    Al Sibae MR; Cappell MS
    Dig Dis Sci; 2011 Apr; 56(4):977-87. PubMed ID: 20844956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
    Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.
    Lee BP; Vittinghoff E; Hsu C; Han H; Therapondos G; Fix OK; Victor DW; Dronamraju D; Im GY; Voigt MD; Rice JP; Lucey MR; Eswaran S; Chen PH; Li Z; Maddur H; Terrault NA
    Hepatology; 2019 Apr; 69(4):1477-1487. PubMed ID: 30561766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-like Effect Associated With Risk of Bleeding, Sepsis, and Death in Patients With Severe Alcohol-Associated Hepatitis.
    Premkumar M; Bihari C; Saxena P; Devurgowda DR; Vyas T; Mirza R; Jain P; Kumar G; Bhatia P; Baweja S; Choudhury A; Sarin SK
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):486-495.e3. PubMed ID: 31077821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey's discriminant function <32.
    Degré D; Stauber RE; Englebert G; Sarocchi F; Verset L; Rainer F; Spindelboeck W; Njimi H; Trépo E; Gustot T; Lackner C; Deltenre P; Moreno C
    J Hepatol; 2020 Apr; 72(4):636-642. PubMed ID: 31954208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial assessment in liver transplantation (LT): an analysis of short-term outcomes.
    Matthews LA; Musto JA; Deiss-Yehiely N; Daniel KE; Lightbourn C; Garvey M; Osman F; Foley DP; Rice JR; Lucey MR
    Hepatol Commun; 2023 Jan; 7(1):e0017. PubMed ID: 36633478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma-Signature-Model for End-Stage Liver Disease Score to Predict Survival in Severe Alcoholic Hepatitis.
    Fujiwara N; Trépo E; Raman I; Li QZ; Degré D; Gustot T; Moreno C; Hoshida Y
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):651-657. PubMed ID: 33667676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation.
    Wedd J; Bambha KM; Stotts M; Laskey H; Colmenero J; Gralla J; Biggins SW
    Liver Transpl; 2014 Oct; 20(10):1193-201. PubMed ID: 24916539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
    Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
    Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.
    Aravinthan AD; Barbas AS; Doyle AC; Tazari M; Sapisochin G; Cattral MS; Ghanekar A; McGilvray ID; Selzner M; Greig PD; Bhat M; Selzner N; Grant DR; Lilly LB; Renner EL
    Transpl Int; 2017 Nov; 30(11):1140-1149. PubMed ID: 28686307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.